BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 12496401)

  • 21. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective expression of the 21-kilodalton tyrosine-phosphorylated form of TCR zeta promotes the emergence of T cells with autoreactive potential.
    Pitcher LA; Mathis MA; Subramanian S; Young JA; Wakeland EK; Love PE; van Oers NS
    J Immunol; 2005 May; 174(10):6071-9. PubMed ID: 15879101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymic expression of a gastritogenic epitope results in positive selection of self-reactive pathogenic T cells.
    Laurie KL; La Gruta NL; Koch N; van Driel IR; Gleeson PA
    J Immunol; 2004 May; 172(10):5994-6002. PubMed ID: 15128782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T lymphocytes in double alpha beta TCR transgenic mice. I. TCR expression and thymus selection in the absence or in the presence of self-antigen.
    Legrand N; Freitas AA
    J Immunol; 2001 Dec; 167(11):6150-7. PubMed ID: 11714774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.
    Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA
    J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture.
    Kersh GJ; Engle DL; Williams CB; Allen PM
    J Immunol; 2000 Jun; 164(11):5675-82. PubMed ID: 10820243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competition for specific intrathymic ligands limits positive selection in a TCR transgenic model of CD4+ T cell development.
    Wong P; Goldrath AW; Rudensky AY
    J Immunol; 2000 Jun; 164(12):6252-9. PubMed ID: 10843678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract.
    Johansson M; Lycke N
    J Immunol; 2003 Feb; 170(4):1659-66. PubMed ID: 12574328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment.
    Doan LL; Kitay MK; Yu Q; Singer A; Herblot S; Hoang T; Bear SE; Morse HC; Tsichlis PN; Grimes HL
    J Immunol; 2003 Mar; 170(5):2356-66. PubMed ID: 12594258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive selection of T cells: rescue from programmed cell death and differentiation require continual engagement of the T cell receptor.
    Kisielow P; Miazek A
    J Exp Med; 1995 Jun; 181(6):1975-84. PubMed ID: 7759993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.
    Coles MC; Raulet DH
    J Immunol; 2000 Mar; 164(5):2412-8. PubMed ID: 10679077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
    Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
    J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: identification of the targets of clonal deletion in an unmanipulated thymus.
    Cho HJ; Edmondson SG; Miller AD; Sellars M; Alexander ST; Somersan S; Punt JA
    J Immunol; 2003 Jan; 170(1):10-3. PubMed ID: 12496375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered selection of CD4+ T cells by class II MHC bound with dominant and low abundance self-peptides.
    Gaszewska-Mastalarz A; Muranski P; Chmielowski B; Kraj P; Ignatowicz L
    J Immunol; 2000 Dec; 165(11):6099-106. PubMed ID: 11086042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
    Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat peripheral CD4+CD8+ T lymphocytes are partially immunocompetent thymus-derived cells that undergo post-thymic maturation to become functionally mature CD4+ T lymphocytes.
    Jiménez E; Sacedón R; Vicente A; Hernández-López C; Zapata AG; Varas A
    J Immunol; 2002 May; 168(10):5005-13. PubMed ID: 11994452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.